Please login to the form below

Not currently logged in
Email:
Password:

ECDC appoints France’s Françoise Weber as chair

Tiiu Aro of Estonia elected deputy chair of the European Centre for Disease Prevention and Control

The European Centre for Disease Prevention and Control (ECDC) has appointed Dr Françoise Weber as chair and Dr Tiiu Aro as deputy chair.

Both terms run until the autumn of 2014, renewable for a further two years, with Dr Weber and Dr Aro leading the EU agency in its aim to support Europe's defence against infectious disease.

Francoise Weber, ECDCTiiu Aro, ECDC
Dr Françoise Weber and Dr Tiiu Aro

Dr Weber, who currently serves as director-general of the French Institute for Public Health Surveillance (InVS), has been a member of ECDC's Board since 2008.

Prior to her time at the InVS, she spent two years as a public health adviser to the French government following a stint as deputy general secretary of the transparency committee of the French Agency for Safety of Health Products (AFSSAPS).

“In recent years, ECDC has provided very high quality support to the EU Institutions and Member States in the prevention and control of infectious diseases,” she said.

“I shall do my utmost to maintain a strong collegial spirit in the board, so that we can support ECDC in facing the challenges ahead, and continue to improve its efficiency, credibility and impact in the fights against infectious diseases.”

Dr Aro is secretary general of the Estonian Ministry of Social Affairs, and has also served as director-general of the Estonian Health Protection Inspectorate, director-general of the Estonian Health Board and as the country's Minister of Health.

She has been a member of ECDC's Board since 2004.

21st November 2012

From: Regulatory, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics